ConvaTec Group PLC AGM Corrected Poll Result (8674N)

TIDMCTEC

RNS Number : 8674N

ConvaTec Group PLC

11 May 2018

Result of Meeting

CONVATEC GROUP PLC - AGM

11 MAY 2018 - CORRECTED POLL RESULT

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today. The results of the poll held in relation to the resolutions proposed at the meeting are set out below. The number of votes withheld has been corrected and a column of number of votes cast included.

 
                         For (see note            Against (see          Number          Number           Total 
                          2)                       note 2)              of votes        of votes        Capital 
                                                                        withheld          cast         Instructed 
                                                                          (see 
                                                                          note 
                                                                           3) 
----------------------  -----------------------  ------------------  ------------                    ------------ 
 Resolution              No of shares    %          No of      % 
                                                    Shares 
----------------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Receive 
       Annual Report 
 1     and Accounts      1,490,995,091   100.00     2,052      0.00     429,366       1,490,997,143     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Approve 
       the Directors' 
       Remuneration 
 2     Report            1,457,090,861   98.33    24,766,857   1.67     9,568,789     1,481,857,718     75.92% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Declare 
 3     Final Dividend    1,490,997,143   100.00       0        0.00     429,366       1,490,997,143     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Re-elect 
       Sir Christopher 
       Gent as 
 4     a Director        1,483,108,674   99.47    7,885,399    0.53     432,436       1,490,994,073     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Re-elect 
       Paul Moraviec 
 5     as a Director     1,488,939,928   99.86    2,054,145    0.14     432,436       1,490,994,073     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Elect Frank 
       Schulkes 
 6     as a Director     1,481,688,827   99.38    9,305,246    0.62      432,436      1,490,994,073     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Re-elect 
       Steve Holliday 
 7     as a Director     1,482,717,535   99.44    8,277,540    0.56   431,434         1,490,995,075     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Re-elect 
       Jesper Ovesen 
 8     as a Director     1,476,891,196   99.05    14,102,877   0.95     432,436       1,490,994,073     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Re-elect 
       Rick Anderson 
 9     as a Director     1,488,985,560   99.87    2,009,487    0.13      431,462      1,490,995,047     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Re-elect 
       Kasim Kutay 
 10    as a Director     1,488,564,111   99.84    2,429,436    0.16      432,962      1,490,993,547     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Elect Ros 
       Rivaz as 
 11    a Director        1,486,522,754   99.70    4,471,319    0.30     432,436       1,490,994,073     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Elect Regina 
       Benjamin 
 12    as a Director     1,488,488,383   99.83    2,506,166    0.17      431,960      1,490,994,549     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Elect Margaret 
       Ewing as 
 13    a Director        1,488,980,460   99.86    2,014,587    0.14      431,462      1,490,995,047     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Re-appoint 
       Deloitte 
 14    LLP as auditors   1,490,989,671   100.00     6,418      0.00      430,420      1,490,996,089     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Authorise 
       the Directors 
       to agree 
       the auditors' 
 15    remuneration      1,490,994,110   100.00     3,033      0.00      429,366      1,490,997,143     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Authorise 
       allotment 
 16    of shares         1,479,661,716   99.25    11,131,674   0.75      633,119      1,490,793,390     76.38% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Disapply 
       pre-emption 
 17    rights*           1,490,781,972   99.99     213,817     0.01      430,720      1,490,995,789     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Disapply 
       pre-emption 
       rights in 
       connection 
       with an 
       acquisition 
       or specified 
       capital 
 18    investment*       1,428,938,102   95.84    62,052,586   4.16      435,820      1,490,990,688     76.39% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Authorise 
       purchase 
 19    of own shares*    1,485,284,913   99.75    3,698,352    0.25     2,443,243     1,488,983,265     76.29% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Authorise 
       political 
       donations 
       and political 
 20    expenditure       1,485,209,550   99.91    1,303,630    0.09     4,913,329     1,486,513,180     76.16% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
      Call general 
       meetings 
       on 14 days' 
 21    notice*           1,442,987,025   97.07    43,526,671   2.93    4,912,813      1,486,513,696     76.16% 
---  -----------------  --------------  -------  -----------  -----  ------------  ----------------  ------------ 
 

*Special Resolution

NOTES:

   1.   All resolutions were passed. 
   2.   Votes "For" and "Against" are expressed as a percentage of votes received. 

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at 6.30pm on 8 May 2018 was 1,951,850,599 shares. Up to 76.39% of voting capital was instructed.

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

This information is provided by RNS

The company news service from the London Stock Exchange

Enquiries

Analysts and Investors

   John Crosse, VP Investor Relations                                             [phone] 
   Kirsty Law, Director Investor Relations                                         [phone] 

[e-mail]

Media

   Bobby Leach, VP Group Corporate Affairs                                    [phone] 

Finsbury [phone]

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

This information is provided by RNS

The company news service from the London Stock Exchange

END

AGMSFDFLFFASEEI

(END) Dow Jones Newswires

May 11, 2018 10:27 ET (14:27 GMT)